<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> have a much increased risk of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> but recent evidence suggests no increase in overall mortality </plain></SENT>
<SENT sid="1" pm="."><plain>We have reexamined this surprising finding in a large, prospectively population-based cohort study </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Cohorts of patients having <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (n=1,677), <z:hpo ids='HP_0100633'>esophagitis</z:hpo> (n=6,392), simple reflux (n=6,328), and a standard reference cohort representing the general population in the United Kingdom (n=13,416) were selected from General Practice Research Database </plain></SENT>
<SENT sid="3" pm="."><plain>The last three cohorts were matched to the Barrett's cohort by general practice, age, and sex </plain></SENT>
<SENT sid="4" pm="."><plain>Mortality rates and hazard ratios with their 95% confidence intervals were calculated for <z:hpo ids='HP_0011420'>deaths</z:hpo> due to <z:hpo ids='HP_0000001'>all</z:hpo> causes and <z:hpo ids='HP_0011420'>deaths</z:hpo> due to <z:hpo ids='HP_0000001'>all</z:hpo> causes except <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> occurring beyond the first year of the follow-up </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: A total of 1,725 <z:hpo ids='HP_0011420'>deaths</z:hpo> were analyzed including 49 <z:hpo ids='HP_0011420'>deaths</z:hpo> in subjects having <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Of 111 <z:hpo ids='HP_0011420'>deaths</z:hpo> in the Barrett's cohort, 13 (12%) were in subjects with <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Compared with the reference cohort, hazard ratios for <z:hpo ids='HP_0000001'>all</z:hpo> causes of <z:hpo ids='HP_0011420'>death</z:hpo> were 1.37 (1.12-1.66) for the Barrett's, 1.16 (1.02-1.32) for the <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, and 1.16 (1.01-1.33) for the reflux cohorts </plain></SENT>
<SENT sid="8" pm="."><plain>The corresponding figures for <z:hpo ids='HP_0011420'>deaths</z:hpo> due to <z:hpo ids='HP_0000001'>all</z:hpo> causes except <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> were 1.23 (1.00-1.51), 1.13 (0.99-1.30), and 1.15 (1.00-1.31) </plain></SENT>
<SENT sid="9" pm="."><plain>Of the excess mortality rates in the Barrett's, <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, and reflux cohorts, at the most 45%, 20%, and 13%, respectively, could be attributed to <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: People with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> have higher mortality rates than the general population, and an increase in <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> risk accounts for less than half the excess mortality in Barrett's </plain></SENT>
</text></document>